AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review
This article was originally published in The Tan Sheet
Executive Summary
AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.
You may also be interested in...
AmerisourceBergen Merger Complete, FTC Says Efficiencies Justify Approval
Federal Trade Commission approval of the merger of AmeriSource and Bergen Brunswig reflects the agency's conclusion that the combined firm will be able to expand its services more rapidly than either company on its own.
AmerisourceBergen Merger Complete, FTC Says Efficiencies Justify Approval
Federal Trade Commission approval of the merger of AmeriSource and Bergen Brunswig reflects the agency's conclusion that the combined firm will be able to expand its services more rapidly than either company on its own.
AmerisourceBergen Merger Complete, FTC Says Efficiencies Justify Approval
Federal Trade Commission approval of the merger of AmeriSource and Bergen Brunswig reflects the agency's conclusion that the combined firm will be able to expand its services more rapidly than either company on its own.